247 related articles for article (PubMed ID: 18434247)
1. Peripheral blood natural killer cells in Crimean-Congo hemorrhagic fever.
Yilmaz M; Aydin K; Akdogan E; Sucu N; Sonmez M; Omay SB; Koksal I
J Clin Virol; 2008 Aug; 42(4):415-7. PubMed ID: 18434247
[TBL] [Abstract][Full Text] [Related]
2. Analysis of lymphocyte subgroups in Crimean-Congo hemorrhagic fever.
Akinci E; Yilmaz M; Bodur H; Ongürü P; Bayazit FN; Erbay A; Ozet G
Int J Infect Dis; 2009 Sep; 13(5):560-3. PubMed ID: 19112036
[TBL] [Abstract][Full Text] [Related]
3. Analysis of risk-factors among patients with Crimean-Congo haemorrhagic fever virus infection: severity criteria revisited.
Ergonul O; Celikbas A; Baykam N; Eren S; Dokuzoguz B
Clin Microbiol Infect; 2006 Jun; 12(6):551-4. PubMed ID: 16700704
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of factors predictive of the prognosis in Crimean-Congo hemorrhagic fever: new suggestions.
Ozturk B; Tutuncu E; Kuscu F; Gurbuz Y; Sencan I; Tuzun H
Int J Infect Dis; 2012 Feb; 16(2):e89-93. PubMed ID: 22154082
[TBL] [Abstract][Full Text] [Related]
5. The effectiveness of routine laboratory findings in determining disease severity in patients with Crimean-Congo hemorrhagic fever: severity prediction criteria.
Yilmaz G; Koksal I; Topbas M; Yilmaz H; Aksoy F
J Clin Virol; 2010 Apr; 47(4):361-5. PubMed ID: 20149724
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of patients with Crimean-Congo hemorrhagic fever in a recent outbreak in Turkey and impact of oral ribavirin therapy.
Ergönül O; Celikbaş A; Dokuzoguz B; Eren S; Baykam N; Esener H
Clin Infect Dis; 2004 Jul; 39(2):284-7. PubMed ID: 15307042
[TBL] [Abstract][Full Text] [Related]
7. Clinical and laboratory features of Crimean-Congo hemorrhagic fever: predictors of fatality.
Cevik MA; Erbay A; Bodur H; Gülderen E; Baştuğ A; Kubar A; Akinci E
Int J Infect Dis; 2008 Jul; 12(4):374-9. PubMed ID: 18063402
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for fatality in patients with Crimean-Congo haemorrhagic fever.
Tasdelen Fisgin N; Tanyel E; Doganci L; Tulek N
Trop Doct; 2009 Jul; 39(3):158-60. PubMed ID: 19535753
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of clinical and laboratory predictors of fatality in patients with Crimean-Congo haemorrhagic fever in a tertiary care hospital in Turkey.
Hatipoglu CA; Bulut C; Yetkin MA; Ertem GT; Erdinc FS; Kilic EK; Sari T; Kinikli S; Oral B; Demiroz AP
Scand J Infect Dis; 2010 Jul; 42(6-7):516-21. PubMed ID: 20166862
[TBL] [Abstract][Full Text] [Related]
10. Crimean-Congo haemorrhagic fever cases in Turkey.
Gozalan A; Esen B; Fitzner J; Tapar FS; Ozkan AP; Georges-Courbot MC; Uzun R; Gumuslu F; Akin L; Zeller H
Scand J Infect Dis; 2007; 39(4):332-6. PubMed ID: 17454897
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the association of serum levels of hyaluronic acid, sICAM-1, sVCAM-1, and VEGF-A with mortality and prognosis in patients with Crimean-Congo hemorrhagic fever.
Ozturk B; Kuscu F; Tutuncu E; Sencan I; Gurbuz Y; Tuzun H
J Clin Virol; 2010 Feb; 47(2):115-9. PubMed ID: 20005156
[TBL] [Abstract][Full Text] [Related]
12. An outbreak of Crimean-Congo hemorrhagic fever in western Anatolia, Turkey.
Ertugrul B; Uyar Y; Yavas K; Turan C; Oncu S; Saylak O; Carhan A; Ozturk B; Erol N; Sakarya S
Int J Infect Dis; 2009 Nov; 13(6):e431-6. PubMed ID: 19409826
[TBL] [Abstract][Full Text] [Related]
13. Cytokine levels in Crimean-Congo hemorrhagic fever.
Papa A; Bino S; Velo E; Harxhi A; Kota M; Antoniadis A
J Clin Virol; 2006 Aug; 36(4):272-6. PubMed ID: 16765637
[TBL] [Abstract][Full Text] [Related]
14. Re-evaluation of 400 Crimean-Congo hemorrhagic fever cases in an endemic area: is ribavirin treatment suitable?
Duygu F; Kaya T; Baysan P
Vector Borne Zoonotic Dis; 2012 Sep; 12(9):812-6. PubMed ID: 22007611
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the associations between endothelial dysfunction, inflammation and coagulation in Crimean-Congo hemorrhagic fever patients.
Doğan HO; Büyüktuna SA; Kapancik S; Bakir S
Arch Virol; 2018 Mar; 163(3):609-616. PubMed ID: 29159591
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical and in situ localization of Crimean-Congo hemorrhagic fever (CCHF) virus in human tissues and implications for CCHF pathogenesis.
Burt FJ; Swanepoel R; Shieh WJ; Smith JF; Leman PA; Greer PW; Coffield LM; Rollin PE; Ksiazek TG; Peters CJ; Zaki SR
Arch Pathol Lab Med; 1997 Aug; 121(8):839-46. PubMed ID: 9278612
[TBL] [Abstract][Full Text] [Related]
17. The efficacy of ribavirin in the treatment of Crimean-Congo hemorrhagic fever in Eastern Black Sea region in Turkey.
Koksal I; Yilmaz G; Aksoy F; Aydin H; Yavuz I; Iskender S; Akcay K; Erensoy S; Caylan R; Aydin K
J Clin Virol; 2010 Jan; 47(1):65-8. PubMed ID: 19962342
[TBL] [Abstract][Full Text] [Related]
18. Mean platelet volume in the diagnosis and prognosis of Crimean-Congo hemorrhagic fever.
Ekiz F; Gürbüz Y; Basar Ö; Aytekin G; Ekiz Ö; Sentürk ÇŞ; Aktas B; Yılmaz B; Altınbaş A; Çoban Ş; Şencan İ
Clin Appl Thromb Hemost; 2013; 19(4):441-4. PubMed ID: 22431857
[TBL] [Abstract][Full Text] [Related]
19. Detection of Crimean-Congo hemorrhagic fever virus genome in saliva and urine.
Bodur H; Akinci E; Ongürü P; Carhan A; Uyar Y; Tanrici A; Cataloluk O; Kubar A
Int J Infect Dis; 2010 Mar; 14(3):e247-9. PubMed ID: 19656706
[TBL] [Abstract][Full Text] [Related]
20. Crimean-Congo hemorrhagic fever.
Whitehouse CA
Antiviral Res; 2004 Dec; 64(3):145-60. PubMed ID: 15550268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
